• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INTRINSIC THERAPEUTICS, INC BARRICAID ACD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INTRINSIC THERAPEUTICS, INC BARRICAID ACD Back to Search Results
Model Number BAR-A8-8MM
Device Problem Failure to Seal (4070)
Patient Problems Bacterial Infection (1735); Pain (1994); Scar Tissue (2060); Hernia (2240)
Event Date 04/07/2022
Event Type  Injury  
Event Description
Patient reported extreme pain during follow-up appointment 12 days after initial implantation.Imaging done showed there was a recurrent disc herniation around the barricaid implant.During revision surgery the doctor used a burr to remove about 3mm inferiorly and superiorly of the lamina and removed about 10% of the facet joint to increase access to the defect area.The nerve was identified and manipulated out of the way.The herniated material was removed and according to the doctor notes, "it was a recurrent disk herniation, or that is what it certainly felt like." the sample was sent to pathology but some of the material was obviously scar tissue and chunks of disc around the scar tissue pocket.Surgeon continued with a discectomy and closed the patient.19 days after revision surgery during a follow-up visit the notes showed the surgery site to have gram-positive rods directly around the barricaid implant.The patient was treated with 4 weeks of ancef.
 
Manufacturer Narrative
Scar tissue is a risk of every discectomy including with barricaid and without barricaid device.The barricaid device is labeled with the risks of scar tissue.Reports of scar tissue have not shown any increases beyond expected rates.Reherniation is an inherent risk of the barricaid device and it is labeled as such.The rates of reherniation have not increased beyond what is expected.The device batch records show the implant used was sterilized, and the type of sterilization would have been able to kill off any traces of gram positive bacteria.There have been no other complaints for infection from this lot therefore intrinsic does not believe our device was the source of this infection.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BARRICAID ACD
Type of Device
BARRICAID
Manufacturer (Section D)
INTRINSIC THERAPEUTICS, INC
30 commerce way
woburn MA 01801
Manufacturer (Section G)
INTRINSIC THERAPEUTICS, INC
30 commerce way
woburn MA 01801
Manufacturer Contact
rachael nelsen
30 commerce way
woburn, MA 01801
7819320252
MDR Report Key16601477
MDR Text Key311926816
Report Number3006232063-2023-00007
Device Sequence Number1
Product Code QES
UDI-Device IdentifierM906BARA88MM0
UDI-PublicM906BARA88MM0
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P160050
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/23/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/23/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberBAR-A8-8MM
Device Catalogue Number2730815-A8
Device Lot Number08162101
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/07/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/25/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-